NMO SPECTRUM DISORDER
Clinical trials for NMO SPECTRUM DISORDER explained in plain language.
Never miss a new study
Get alerted when new NMO SPECTRUM DISORDER trials appear
Sign up with your email to follow new studies for NMO SPECTRUM DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug B001 tested for rare autoimmune disease
Disease control Recruiting nowThis early-phase trial tests a new drug called B001 in 45 people with a rare autoimmune disease called NMOSD. The study aims to check if B001 is safe, how the body processes it, and whether it might help control the disease. Participants must have had at least one relapse in the …
Matched conditions: NMO SPECTRUM DISORDER
Phase: EARLY_PHASE1 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New registry study tests antibody drugs for rare nerve disease
Disease control Recruiting nowThis registry study is tracking 200 people with a rare autoimmune disease called neuromyelitis optica spectrum disorder (NMOSD) who are positive for the AQP4 antibody. Researchers are evaluating how well monoclonal antibody therapies work in real-world settings, focusing on preve…
Matched conditions: NMO SPECTRUM DISORDER
Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 26, 2026 14:35 UTC
-
Could zapping the brain ease nerve pain in NMOSD?
Symptom relief Recruiting nowThis study tests a non-invasive brain stimulation device (tTIS) to see if it can safely reduce neuropathic pain in people with neuromyelitis optica spectrum disorder (NMOSD). Twelve participants will receive the stimulation and report their pain levels. The goal is to find a new,…
Matched conditions: NMO SPECTRUM DISORDER
Phase: NA • Sponsor: Tang-Du Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New study uses advanced scans to map brain inflammation over time
Knowledge-focused Recruiting nowThe CLUE study is a research project that follows 1,000 people with neuroinflammatory diseases like multiple sclerosis and neuromyelitis optica. Participants undergo detailed MRI and PET scans at the start and after one year to see how their brain, spinal cord, and optic nerves c…
Matched conditions: NMO SPECTRUM DISORDER
Sponsor: Beijing Tiantan Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
AI set to revolutionize MS diagnosis and monitoring
Knowledge-focused Recruiting nowThis study gathers health data from 7,000 people with multiple sclerosis (MS) and related conditions. The goal is to use this information to train artificial intelligence (AI) tools that can help doctors diagnose MS earlier and predict how the disease will progress. No new treatm…
Matched conditions: NMO SPECTRUM DISORDER
Sponsor: icometrix • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC